Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial

BACKGROUND: Whole brain radiotherapy (WBRT) and dexamethasone are widely used to treat brain metastases from non-small cell lung cancer (NSCLC), although there have been no randomised clinical trials showing that WBRT improves either quality of life or overall survival. Even after treatment with WBR...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Lancet
Main Authors: Mulvenna, Paula, Nankivell, Matthew, Barton, Rachael, Faivre-Finn, Corinne, Wilson, Paula, McColl, Elaine, Moore, Barbara, Brisbane, Iona, Ardron, David, Holt, Tanya, Morgan, Sally, Lee, Caroline, Waite, Kathryn, Bayman, Neil, Pugh, Cheryl, Sydes, Benjamin, Stephens, Richard, Parmar, Mahesh K, Langley, Ruth E
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2016
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5082599/
https://ncbi.nlm.nih.gov/pubmed/27604504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(16)30825-X
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki